TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
+10.28%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$5.78B
AUM Growth
+$1.86B
(+48%)
Cap. Flow
+$1.56B
Cap. Flow
% of AUM
26.98%
Top 10 Holdings %
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,123
Increased
2,719
Reduced
2,325
Closed
681
Top Buys
| 1 |
Apple
AAPL
|
+$132M |
| 2 |
Microsoft
MSFT
|
+$129M |
| 3 |
Amazon
AMZN
|
+$89.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.7M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$51.8M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$84.8M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$43.2M |
| 4 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$36.3M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$20.9M |
Sector Composition
| 1 | Technology | 25.13% |
| 2 | Consumer Discretionary | 10.53% |
| 3 | Financials | 9.89% |
| 4 | Healthcare | 8.91% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGO
3326
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $28K | ﹤0.01% |
1,180
+747
| +173% | +$17.7K |
|
|
SRRA
3327
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $28K | ﹤0.01% |
+1,305
| New | +$28K |
|
|
RBNC
3328
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $28K | ﹤0.01% |
771
-576
| -43% | -$20.9K |
|
|
FBC
3329
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $28K | ﹤0.01% |
575
-18,958
| -97% | -$923K |
|
3330
Abits Group
ABTS
$13.1M
| $27K | ﹤0.01% |
+627
| New | +$27K |
|
3331
ATN International
ATNI
$239M
| $27K | ﹤0.01% |
671
+482
| +255% | +$19.4K |
|
3332
Atlanta Braves Holdings Series A
BATRA
$2.85B
| $27K | ﹤0.01% |
955
+217
| +29% | +$6.14K |
|
3333
Biodesix
BDSX
$53.8M
| $27K | ﹤0.01% |
5,111
+3,450
| +208% | +$18.2K |
|
3334
Sierra Bancorp
BSRR
$422M
| $27K | ﹤0.01% |
991
-372
| -27% | -$10.1K |
|
3335
Bank7 Corp
BSVN
$462M
| $27K | ﹤0.01% |
1,151
+1,015
| +746% | +$23.8K |
|
|
CMCT
3336
Creative Media & Community Trust
CMCT
$5.47M
| $27K | ﹤0.01% |
15
+13
| +650% | +$23.4K |
|
3337
Cue Biopharma
CUE
$56.1M
| $27K | ﹤0.01% |
2,373
-414
| -15% | -$4.71K |
|
3338
Design Therapeutics
DSGN
$356M
| $27K | ﹤0.01% |
1,271
+825
| +185% | +$17.5K |
|
3339
Euronet Worldwide
EEFT
$3.54B
| $27K | ﹤0.01% |
227
-199
| -47% | -$23.7K |
|
3340
Erasca
ERAS
$530M
| $27K | ﹤0.01% |
1,735
+754
| +77% | +$11.7K |
|
|
EVRI
3341
DELISTED
Everi Holdings
EVRI
| $27K | ﹤0.01% |
1,272
-7,980
| -86% | -$169K |
|
3342
iShares MSCI Canada ETF
EWC
$3.3B
| $27K | ﹤0.01% |
693
-330
| -32% | -$12.9K |
|
3343
Flora Growth
FLGC
$14.9M
| $27K | ﹤0.01% |
19
+18
| +1,800% | +$25.6K |
|
3344
Frontline
FRO
$5.31B
| $27K | ﹤0.01% |
3,831
-93
| -2% | -$655 |
|
3345
Janux Therapeutics
JANX
$1.47B
| $27K | ﹤0.01% |
1,384
+862
| +165% | +$16.8K |
|
3346
James River Group
JRVR
$247M
| $27K | ﹤0.01% |
953
-3,297
| -78% | -$93.4K |
|
3347
Ranpak Holdings
PACK
$438M
| $27K | ﹤0.01% |
721
-3,165
| -81% | -$119K |
|
3348
Pembina Pipeline
PBA
$23.1B
| $27K | ﹤0.01% |
900
+30
| +3% | +$900 |
|
3349
Q2 Holdings
QTWO
$5.26B
| $27K | ﹤0.01% |
340
-10,908
| -97% | -$866K |
|
3350
Construction Partners
ROAD
$7.34B
| $27K | ﹤0.01% |
933
-535
| -36% | -$15.5K |
|